Systemic Bio
Houston
About Systemic Bio
Systemic Bio creates bioprinted organs-on-chips for drug discovery and development. Its proprietary platform is built with production-level 3D Systems technology, which has at least 10x greater build volume and up to 10x higher resolution than commercially available technologies.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $15.0M
- Funding stage: Seed
- Last round: Seed (Sep 2022)
- Website: systemic.bio
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/systemic-bio-51868 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.